Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
Go back to Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market| (NASDAQ: INBS) | Delayed: 1.81 +0.01 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.80 | 52 Week High | $ | |||
| Open | $1.80 | 52 Week Low | $ | |||
| Day High | $1.88 | P/E | N/A | |||
| Day Low | $1.75 | EPS | $ | |||
| Volume | 58,561 | |||||
| (NASDAQ: INBS) | Delayed: 1.81 +0.01 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.80 | 52 Week High | $ | |||
| Open | $1.80 | 52 Week Low | $ | |||
| Day High | $1.88 | P/E | N/A | |||
| Day Low | $1.75 | EPS | $ | |||
| Volume | 58,561 | |||||

